Related Experiment Video
Updated: Mar 28, 2026

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
19.5K
HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights
Amin Khademi1, Denis Saure2, Andrew Schaefer3
1Department of Industrial Engineering, Clemson University, Clemson, SC, USA.
Summary
A new cumulative incidence-based coverage definition offers a more accurate measure of long-term success for HIV treatment programs. This approach improves understanding of HIV treatment progress beyond current World Health Organization (WHO) metrics.
Area of Science:
- Epidemiology
- Public Health
- Health Policy
Background:
- Antiretroviral treatment (ART) for HIV is complex, improving individual survival and reducing transmission.
- Current HIV coverage metrics may overestimate program performance by not accounting for untreated disease acquisition or mortality.
- Standard metrics can be influenced by the deaths of untreated individuals.
Purpose of the Study:
- To propose an alternative coverage definition for HIV treatment programs.
- To develop a metric that better reflects long-run program performance.
- To enhance the evaluation of HIV/AIDS interventions.
Main Methods:
- Introduced cumulative incidence-based coverage as a novel metric.
- Utilized an extended simulation model of HIV disease and treatment dynamics.
- Incorporated uninfected and HIV-infected individuals in a dynamic population model.
- Estimated resource needs for diverse treatment policies in resource-limited settings.
Main Results:
- A synthetic population analysis revealed a potential 16% discrepancy over 10 years compared to the WHO definition.
- The study considered 600,000 individuals, with 44,000 (7.6%) infected and eligible for treatment (CD4 < 500 cells/mm³).
- A 50% WHO-defined coverage rate was assumed for treatment initiation.
Conclusions:
- The cumulative incidence-based coverage definition provides a more accurate assessment of long-term HIV treatment success.
- This new metric, alongside existing definitions, enhances the understanding of HIV treatment program progress.
- Accurate coverage measurement is crucial for effective HIV/AIDS epidemic control.
Related Concept Videos
Retrovirus Life Cycles
50.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.6K
Sexually Transmitted Infections
1.6K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.6K
Pulmonary Tuberculosis I
1.4K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K
Immunodeficiency Diseases
3.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
3.0K
Pulmonary Tuberculosis V
827
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
827
Treatment Resistent Cancers
1.5K
1.5K

